

Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases. Among its major competitors, Apellis Pharmaceuticals is ranked in 6th place for NPS while Biogen is 1st, and Athersys is 2nd. Overall, Apellis Pharmaceuticals has a neutral social sentiment, when analyzing social media channels and online mentions.Their current valuation is $10.43B
Apellis Pharmaceuticals has a 3.1/5 stars for its overall company culture rated by their employees

In the Bottom 5% of Similar Sized Companies on Comparably.